Clinical Trials Browser

Pituitary ACTH Hypersecretion × 90 days × Clear all

Combined Pituitary Hormone Deficiency, Congenital Abnormalities, Acromegaly, Gigantism, Prolactinoma, Pituitary ACTH Hypersecretion, Carcinogenesis

NCT03604198 2026-04-21

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Phase 2 Active not recruiting

125 enrolled

Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Adrenocortical Carcinoma, Pituitary ACTH Hypersecretion

NCT04569591 2026-04-09

DDAVP for Pituitary Adenoma

Phase NA Recruiting

22 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT07463625 2026-03-11

PiTFET

Recruiting

20 enrolled

Endocrine

Pituitary Diseases, Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

NCT07460232 2026-03-10

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Phase EARLY_PHASE1 Not yet recruiting

50 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

Clinical Trials

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

DDAVP for Pituitary Adenoma

PiTFET

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease